Showing results (1661-1670 of 7,735) with videos related to
Sort By:
Pageof 774
Nature Reviews. Cancer|September 25, 2008
The TRAIL apoptotic pathway in cancer onset, progression and therapyRicky W Johnstone, Ailsa J Frew, Mark J SmythNature Reviews. Immunology|July 31, 2020
Targeting CD39 in cancerAchim K Moesta, Xian-Yang Li, Mark J SmythJournal of Forensic Nursing|February 20, 2015
Childhood adversity, mental health, and violent crimeKathleen Brewer-Smyth, Monica E Cornelius, E Elisabeth PickelsimerJournal of Motor Behavior|August 10, 2001
Visual information and the control of reaching in children: a comparison between children with and without developmental coordination disorderM M Smyth, H I Anderson, A C ChurchillAmerican Journal of Medical Genetics. Part A|May 16, 2003
Chiari I malformation and cloacal exstrophy: report of a patient with both defects of blastogenesisR Shane Tubbs, Matthew D Smyth, W Jerry OakesJournal of Industrial Microbiology & Biotechnology|March 28, 2013
Sporicidal efficacy of pH-adjusted bleach for control of bioburden on production facility surfacesAnne Cornish Frazer, Josephine N Smyth, Vishvesh K BhupathirajuBMJ (Clinical Research Ed.)|January 5, 2012
Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional studyAndrew P Prayle, Matthew N Hurley, Alan R SmythClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2013
Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbsBertrand Allard, Sandra Pommey, Mark J Smyth, et al.Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|October 22, 2014
Characterization of postoperative fevers after hemispherotomyAshwin A Kamath, David L Limbrick, Matthew D SmythImmunity|July 30, 2013
Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillanceLaurence Zitvogel, Lorenzo Galluzzi, Mark J Smyth, et al.Pageof 774